Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARRY-371797 for dental pain after third molar extraction
NCT00542035Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in odontalgia comparing ARRY-371797, Placebo, ARRY-371797 and Placebo (3 arms). Primary endpoints: Total Pain Relief at 6 hours, Visual Analog Scale at 6 hours and 1 more. Started Nov 2007; status: completed.
02
Drugs
emprumapimod
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT00542035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542035.